期刊文献+

钆贝葡胺延时1h肝胆期扫描对肝脏良恶性病灶的信号分析价值

Gd-BoPTA scan of one-hour delayed hepatobiliary phase of benign and malignant lesions of the liver: value of signal analysis
下载PDF
导出
摘要 目的观察钆贝葡胺注射液(gadobenate dimeglumine injection,Gd-BOPTA)作为磁共振的特异性对比剂,在1h延时肝胆期肝脏病灶的信号强度,分析良恶性病灶的信号特征及与病理的关系。方法可疑肝脏病变50例,共70个肝脏病灶行MR平扫、BOPTA动态增强及1 h延时并2周内经穿刺活检病理诊断或手术证实。记录各种病灶在T1平扫及1 h肝胆期的信号强度,计算各种病灶的信噪比(SNR)及对噪比(CNR)并做统计学分析。结果 1 h延时后,97.8%的恶性病灶表现为低信号,40%的良性病灶表现为低信号,二者有统计学意义(P<0.05)。SNR、CNR值存在不同程度的差异。结论典型的恶性病灶的组织学特征反映出的钆贝葡胺核磁增强肝胆期低信号改变,而一些良性病灶由于内部结构的原因,也可表现为低信号,鉴别诊断依然存在困难。 Objective To observe the images with injection of Gd-BOPTA(gadobenate dimeglumine,Gd-BOPTA injection,multihance) as the dual phase MRI contrast agent and after the acquisition of one-hour delayed hepatobiliary-phase images and to analyze signal attenuation and characteristics in both benign and malignant liver lesions after intravenous bolus administration of Gd-BOPTA.Methods Fifty patients were suspected of having liver lesions.The seventy liver lesions of theirs underwent MRI scan and were confirmed by biopsy pathological diagnosis or operation in two weeks.The lesion to liver contrast/noise ratio(CNR) and signal/noise ratio(SNR)were calculated both in benign and malignant liver lesions.Results After one-hour delay,97.8% of the malignant lesions and 40% of the benign lesions showed low signal.There was statistically significant difference between the two groups(P0.05).SNR and CNR illustrated some difference in benign and malignant lesions.Conclusions Although the hypointense signal in the hepatobiliary-phase of the Gd-BOPTA enhanced magnetic resonance imaging was typically a histological feature of malignant lesions in liver lesions,some of the benign lesions also showed a similar signal due to the internal structure.Differential diagnosis betweem benign liver lesions and malignant ones remains difficult.
出处 《武警医学》 CAS 2012年第3期196-200,共5页 Medical Journal of the Chinese People's Armed Police Force
关键词 磁共振对比剂 磁共振成像 钆贝葡胺 肝脏局灶性病变 MRI contrast agent magnetic resonance imaging gadobenate dimeglumine focal liver lesions
  • 相关文献

参考文献12

  • 1Grazioli L,Bondioni M P,Faccioli N.Solid focal liverlesions:dynamic and late enhancement patterns with thedual phase contrast agent gadobenate dimeglumine[J].Gastrointest Cancer,2010,41(4):221-232.
  • 2Morana G,Grazioli L,Kirchin M A.Solid hypervascularliver lesions:accurate identification of true benign lesionson enhanced dynamic and hepatobiliary phase magneticresonance imaging after gadobenate dimeglumine adminis-tration[J].Invest Radiol,2011,46(4):225-239.
  • 3Seale M K,Catalano O A,Saini S,et al.Hepatobiliary-specific MR contrast agents:role in imaging the liver andbiliary tree[J].Radiographics,2009,29(6):1725-1748.
  • 4Hwang H S,Kim S H,Jeon T Y.Hypointense hepaticlesions depicted on gadobenate dimeglumine-enhancedthree-hour delayed hepatobiliary-phase MR imaging:differentiation between benignancy and malignancy[J].Korean J Radiol,2009,10(3):294-302.
  • 5Schneider G,Altmeyer K,Kirchin M A,et al.Evaluationof a novel time-efficient protocol for gadobenate dimeglu-mine(Gd-BOPTA)-enhanced liver magnetic resonanceimaging[J].Invest Radiol,2007,42(2):105-115.
  • 6Grazioli L,Morana G,Kirchin M A.Accurate differentia-tion of focal nodular hyperplasia from hepatic adenoma atgadobenate dimeglumine-enhanced MR imaging:pro-spective study[J].Radiology,2005,236(1):166-177.
  • 7Brancatelli G,Federle M P,Grazioli L.Benign regener-ative nodules in Budd-Chiari syndrome and other vas-cular disorders of the liver:radiologic-pathologic andclinical correlation[J].Radiographics,2002,22(4):847-862.
  • 8Brancatelli G,Federle M P,Grazioli L.Large regenera-tive nodules in Budd-Chiari syndrome and other vascu-lar disorders of the liver:CT and MR imaging findingswith clinicopathologic correlation[J].AJR,2002,178(4):877-883.
  • 9张红梅,欧阳汉,周纯武.钆贝酸葡甲胺与钆喷替酸葡甲胺在肝脏MRI增强扫描中的应用与评价[J].中华肿瘤杂志,2006,28(2):111-115. 被引量:7
  • 10张国福,周康荣,严福华,沈继章,施卫斌,张澍杰,陈财忠,张来.Gd-BOPTA增强MRI对小肝癌的诊断价值[J].临床放射学杂志,2004,23(12):1052-1057. 被引量:12

二级参考文献44

  • 1汪剑,陆建平,田建明,王飞,刘崎,王莉,龚建国,金爱国,曾浩.3D-FS-FLASH序列在肝细胞癌MRI诊断中的应用价值[J].中国医学影像技术,2003,19(6):699-701. 被引量:2
  • 2汪登斌,周康荣,陈克敏,陈憩,展颖,唐永华.MRI MnDPDP增强对原发性肝细胞癌的诊断价值[J].中国医学影像学杂志,2002,10(1):1-4. 被引量:3
  • 3[3]Low RN,Francis IR,Sigeti JS,et al.Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo,and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging.Radiology,1993,186:803
  • 4[4]Whiteney WS,Herfken RJ,Jeffrey RB,et al.Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with Gadolinium-enhancement for differentiating hepatic hemangiomas from malignancies at 1.5T.Radiology,1993,189:863
  • 5[5]Fujita T,Ito K,Honjo K,et al.Detection of hepatocellular carcinoma: comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil.J Magn Reson Imaging,1999,9:274
  • 6[7]Toft KG,Hustvedt SO,et al.Metabolism and pharmacokinetics of Mn-DPDP in man.Acta Radiologica,1997,38:677
  • 7[8]Hannhn PF and Saini S.Liver-specific MR imaging contrast agents.Radiol Clini Nor Am,1998,36:287
  • 8[9]Kirchin MA,Pirovano GP,Spinazzi A.Gadobenate dimeglumine (Gd-BOPTA): an overview.Invest Radiol,1998,33:798
  • 9[10]Spinazzi A,Lorusso V,Pirovano G,et al.Safety,tolerance,biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.Acad Radiol,1999,6:282
  • 10[11]Kirchin MA,Pirovano G,Venetianer C,et al.Safety assessment of gadobenate dimeglumine (Multihance): extended clinical experience from phase Ⅰ studies to post-marketing surveillance.J Magn Reson Imaging,2001,14:281

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部